Stockreport

Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch [Seeking Alpha]

Immix Biopharma, Inc.  (IMMX) 
PDF Prior to joining Immix, Grabow was Head of Commercial Operations at Chimerix where he led Go-To-Market Strategy and Launch of orphan drug MODEYSO, the company said. I [Read more]